beichangping cofrogliptin tablets diabetes 5mg package

Description

Indication & Scope

Cofrogliptin Tablets improves glycemic control in adult patients with type 2 diabetes mellitus.

Mechanism: Selective DPP-4 inhibitor, inhibits dipeptidyl peptidase 4 to prolong endogenous GLP-1 and GIP half-life. Increases insulin secretion and suppresses glucagon release in a glucose-dependent manner to lower blood glucose.
Drug class: DPP-4 inhibitor, oral anti-diabetic agent.
Clinical use: Monotherapy or combination therapy with metformin for glycemic control in adults with type 2 diabetes.

Specification

Generic Name	Cofrogliptin Tablets
Brand Name	BeiChangPing
Ingredient	Cofrogliptin Tablets
Dosage Form	Tablets
Package	5mg*4 tablets/box
Conditions Treated	Type 2 diabetes mellitus in adult patients
Taboos	1. Hypersensitivity to cofrogliptin or tablet excipients 2. History of severe pancreatitis related to DPP-4 inhibitor class drugs 3. End-stage renal disease requiring dialysis
Place of origin	China
Prescription type	Prescription-only
Storage Conditions	Sealed, dry and light-proof storage below 30°C
Manufacturer	HaiSiKe Pharmaceutical Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval number	H20240024
Approval Date	Jun 18, 2024
Shelf Life	24 months

How to use ?

Recommended Dose: 10 mg orally, no dosage titration required.

Time: Taken every 2 weeks.

Instructions for use:

1. Swallow tablets whole with plain water.

2. Monitor patients for persistent abdominal pain suggestive of pancreatitis.

3. Dose adjustment is required for moderate to severe renal impairment.

4. No dose adjustment needed for hepatic dysfunction.

Interaction:

1. No major CYP450 metabolic interactions with most common anti-diabetic medications.

2. Concomitant sulfonylureas increase hypoglycemia risk.

3. Angiotensin converting enzyme inhibitors slightly raise risk of angioedema.

Side effects:

1. Common: Nasopharyngitis, headache, arthralgia, upper respiratory tract infection
2. Severe: Acute pancreatitis, severe hypersensitivity angioedema, bullous pemphigoid

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support